A comprehensive meta-analysis confirmed that elevated Gal-3 post-AMI was a significant predictor of all-cause mortality (HR 1.78), cardiovascular mortality (HR 1.92), and HF hospitalization (HR 1.54) (Tian et al., 2020). This evidence concerns the gene LGALS3 and hydrops fetalis.